T1	PROC 91 117	tratamiento complementario
#1	AnnotatorNotes T1	C0936077; Complementary therapies; Therapeutic or Preventive Procedure
T2	CHEM 120 130	donepezilo
#2	AnnotatorNotes T2	C0527316; donepezil; Organic Chemical · Pharmacologic Substance
T3	DISO 148 171	enfermedad de Alzheimer
#3	AnnotatorNotes T3	C0002395; Alzheimer's Disease; Disease or Syndrome
T4	PROC 210 238	Estudio de extensión abierto
T5	PROC 244 283	evaluar la seguridad y la tolerabilidad
T6	PROC 317 343	tratamiento complementario
#4	AnnotatorNotes T6	C0936077; Complementary therapies; Therapeutic or Preventive Procedure
T7	CHEM 346 356	donepezilo
#5	AnnotatorNotes T7	C0527316; donepezil; Organic Chemical · Pharmacologic Substance
T8	DISO 374 397	enfermedad de Alzheimer
#6	AnnotatorNotes T8	C0002395; Alzheimer's Disease; Disease or Syndrome
T9	DISO 437 460	Enfermedad de Alzheimer
#7	AnnotatorNotes T9	C0002395; Alzheimer's Disease; Disease or Syndrome
T10	PROC 553 624	estudios clínicos de pre inclusión doble ciegos controlados con placebo
T11	CHEM 1197 1200	IAC
#8	AnnotatorNotes T11	C0007036; Carbonic Anhydrase Inhibitors; Pharmacologic Substance
T12	DISO 695 717	acontecimiento adverso
#9	AnnotatorNotes T12	C0877248; Adverse event; Pathologic Function
T13	DISO 873 891	crisis epilépticas
#10	AnnotatorNotes T13	C4317109; Epileptic Seizures; Disease or Syndrome
T14	DISO 979 1003	signos de una enfermedad
T16	PROC 1176 1187	tratamiento
#12	AnnotatorNotes T16	C0087111; Therapeutic procedure; Therapeutic or Preventive Procedure
T17	CHEM 1207 1216	memantina
#13	AnnotatorNotes T17	C0025242; memantine; Organic Chemical · Pharmacologic Substance
T18	CHEM 1102 1112	donepezilo
#14	AnnotatorNotes T18	C0527316; donepezil; Organic Chemical · Pharmacologic Substance
T19	CHEM 75 85	Lu AE58054
#15	AnnotatorNotes T19	C3253508; Lu AE58054; Organic Chemical · Pharmacologic Substance
T20	CHEM 301 311	Lu AE58054
#16	AnnotatorNotes T20	C3253508; Lu AE58054; Organic Chemical · Pharmacologic Substance
T21	Date 13 17	2013
T22	LIVB 134 143	pacientes
#17	AnnotatorNotes T22	C0030705; Patients; Patient or Disabled Group
T23	Date 284 297	a largo plazo
T24	LIVB 360 369	pacientes
#18	AnnotatorNotes T24	C0030705; Patients; Patient or Disabled Group
T25	LIVB 492 500	paciente
#19	AnnotatorNotes T25	C0030705; Patients; Patient or Disabled Group
T26	LIVB 674 682	paciente
#20	AnnotatorNotes T26	C0030705; Patients; Patient or Disabled Group
T27	LIVB 789 801	investigador
#21	AnnotatorNotes T27	C0035173; Research Personnel; Professional or Occupational Group
T30	LIVB 854 862	paciente
#22	AnnotatorNotes T30	C0030705; Patients; Patient or Disabled Group
T31	LIVB 961 969	paciente
#23	AnnotatorNotes T31	C0030705; Patients; Patient or Disabled Group
T32	Spec_cue 1037 1045	probable
T33	LIVB 1117 1125	paciente
#24	AnnotatorNotes T33	C0030705; Patients; Patient or Disabled Group
T34	LIVB 1151 1159	paciente
#25	AnnotatorNotes T34	C0030705; Patients; Patient or Disabled Group
T35	Date 769 781	preinclusión
T28	Date 942 954	preinclusión
T29	PROC 515 521	Visita
#26	AnnotatorNotes T29	C1512346; Patient Visit; Health Care Activity
T36	PROC 538 544	Visita
#27	AnnotatorNotes T36	C1512346; Patient Visit; Health Care Activity
T37	PROC 904 910	visita
#28	AnnotatorNotes T37	C1512346; Patient Visit; Health Care Activity
T38	CONC 525 537	Finalización
#29	AnnotatorNotes T38	C4283764; Trial participation end date; Temporal Concept
T39	CONC 904 954	visita de finalización del estudio de preinclusión
T40	Quantifier_or_Qualifier 522 523	7
#31	AnnotatorNotes T5	C1705187; Safety Study; Research Activity + C3274448; Tolerability Study; Research Activity 
#32	AnnotatorNotes T14	C0037088; Signs and Symptoms; Sign or Symptom
#33	AnnotatorNotes T23	C0443252; Long-term; Temporal Concept
T41	Spec_cue 815 822	posible
T42	Observation 823 847	riesgo para la seguridad
A2	Assertion T42 Speculated
T43	PROC 1059 1097	interrumpir o suspender el tratamiento
A3	Assertion T43 Speculated
#34	AnnotatorNotes T43	C0850893; stop medication; Therapeutic or Preventive Procedure | C4288399; Pharmacotherapy Discontinuation; Therapeutic or Preventive Procedure
R1	Speculation Arg1:T32 Arg2:T43	
R3	Speculation Arg1:T41 Arg2:T42	
R4	Experiences Arg1:T26 Arg2:T12	
R5	Experiences Arg1:T26 Arg2:T42	
T44	Quantifier_or_Qualifier 718 726	moderado
#35	AnnotatorNotes T44	C0205081; Moderate (severity modifier); Qualitative Concept
R6	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T44	
T45	Quantifier_or_Qualifier 729 736	intenso
#36	AnnotatorNotes T45	C0522510; With intensity; Qualitative Concept
R7	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T45	
T46	Quantifier_or_Qualifier 737 748	persistente
#37	AnnotatorNotes T46	C0205322; Persistent; Temporal Concept
R8	Has_Quantifier_or_Qualifier Arg1:T12 Arg2:T46	
T47	PROC 758 765	estudio
#38	AnnotatorNotes T47	C2603343; Study; Research Activity
R9	Overlap Arg1:T47 Arg2:T35	
R10	Before Arg1:T47 Arg2:T12	
R12	Experiences Arg1:T30 Arg2:T13	
R14	Before Arg1:T13 Arg2:T39	
T48	PROC 931 938	estudio
#39	AnnotatorNotes T48	C2603343; Study; Research Activity
R15	Overlap Arg1:T48 Arg2:T28	
T49	Quantifier_or_Qualifier 1004 1030	clínicamente significativa
R13	Has_Quantifier_or_Qualifier Arg1:T14 Arg2:T49	
R16	Experiences Arg1:T31 Arg2:T14	
R17	Experiences Arg1:T34 Arg2:T16	
R18	Used_for Arg1:T11 Arg2:T16	
R19	Used_for Arg1:T17 Arg2:T16	
T50	Quantifier_or_Qualifier 1192 1196	otro
#30	AnnotatorNotes T50	C0205394; Other; Qualitative Concept
R20	Has_Quantifier_or_Qualifier Arg1:T11 Arg2:T50	
R21	Used_for Arg1:T19 Arg2:T1	
R23	Experiences Arg1:T22 Arg2:T19	
R24	Experiences Arg1:T22 Arg2:T2	
R25	Experiences Arg1:T22 Arg2:T3	
R28	Overlap Arg1:T5 Arg2:T23	
R29	Experiences Arg1:T24 Arg2:T20	
R31	Used_for Arg1:T20 Arg2:T6	
R32	Experiences Arg1:T24 Arg2:T7	
R33	Experiences Arg1:T24 Arg2:T8	
T53	Quantifier_or_Qualifier 172 187	leve o moderada
#42	AnnotatorNotes T53	C1299392; Mild to moderate; Qualitative Concept
R34	Has_Quantifier_or_Qualifier Arg1:T3 Arg2:T53	
T54	Quantifier_or_Qualifier 398 413	leve o moderada
#43	AnnotatorNotes T54	C1299392; Mild to moderate; Qualitative Concept
R35	Has_Quantifier_or_Qualifier Arg1:T8 Arg2:T54	
R36	Has_Quantifier_or_Qualifier Arg1:T29 Arg2:T40	
T55	Observation 504 521	completado Visita
R39	Used_for Arg1:T18 Arg2:T43	
T56	PROC 1137 1144	estudio
#44	AnnotatorNotes T56	C0008976; Clinical Trials; Research Activity
R41	Overlap Arg1:T43 Arg2:T56	
#40	AnnotatorNotes T49	C5209294; Clinical relevance; Intellectual Product
R11	Experiences Arg1:T25 Arg2:T29	
R22	Experiences Arg1:T25 Arg2:T36	
R26	Experiences Arg1:T30 Arg2:T37	
#11	AnnotatorNotes T4	C1709323; Open Label Study; Research Activity (?)
A1	Experiencer T22 Patient
A4	Experiencer T24 Patient
A5	Experiencer T25 Patient
A6	Experiencer T26 Patient
A7	Experiencer T27 Other
A8	Experiencer T30 Patient
A9	Experiencer T31 Patient
A10	Experiencer T33 Patient
A11	Experiencer T34 Patient
R2	Experiences Arg1:T33 Arg2:T43	
